Financial News

My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICU Medical, Inc. - Common Stock (NQ:ICUI)

113.03 -3.86 (-3.30%)
Streaming Delayed Price Updated: 2:34 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ICU Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
ICU Medical Announces Time of First Quarter 2023 Earnings Conference Call
From ICU Medical, Inc.
Via GlobeNewswire
ICU Medical to Participate at the KeyBanc Life Sciences & MedTech Investor Forum
From ICU Medical, Inc.
Via GlobeNewswire
ICU Medical Earnings Perspective: Return On Capital Employed
 
Via Benzinga
ICU Medical Announces Fourth Quarter 2022 Results and Provides Fiscal Year 2023 Guidance
From ICU Medical, Inc.
Via GlobeNewswire
ICU Medical's Earnings: A Preview
 
Via Benzinga
ICU Medical's Return On Capital Employed Insights
 
Via Benzinga
FDA Signals Shortage Of ICU Medical's Tracheostomy Tubes
 
Via Benzinga
Smiths Acquisition Weighs On ICU Medical's Profitability, Shares Fall
 
Via Benzinga
Earnings Scheduled For February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
Expert Ratings for ICU Medical
  Analysts have provided the following ratings for ICU Medical (NASDAQ:ICUI) within the last quarter: 
Via Benzinga
ICU Medical to Present at the Raymond James 44th Annual Institutional Investors Conference
From ICU Medical, Inc.
Via GlobeNewswire
ICU Medical Announces Time of Fourth Quarter 2022 Earnings Conference Call
From ICU Medical, Inc.
Via GlobeNewswire
ICU Medical to Present at the J.P. Morgan 41st Annual Healthcare Conference
From ICU Medical, Inc.
Via GlobeNewswire
ICU Medical: Q2 Earnings Insights
  ICU Medical (NASDAQ:ICUI) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Raymond James Says 'Supply Chain Challenges Made Q1 Messy' For This Medtech Stock
 
Via Benzinga
TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune
Via AB Newswire
Topics Death Economy Stocks
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Upgrades 
Via Benzinga
ICU Medical Announces Third Quarter 2022 Results
The Company Reaffirms 2022 Fiscal Year Guidance 
From ICU Medical, Inc.
Via GlobeNewswire
Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization From Next Year: Top Stories Tuesday, Nov. 01
Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production 
Via Benzinga
ICU Medical Announces Time of Third Quarter 2022 Earnings Conference Call
From ICU Medical, Inc.
Via GlobeNewswire
Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading. 
Via Benzinga
This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes
Wells Fargo cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $49 to $42. However, Wells Fargo analyst Brian Fitzgerald maintained the stock with an Overweight. Lyft shares rose 0.6% to $20.41 in... 
Via Benzinga
Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
ICU Medical's Return On Capital Employed Insights
ICU Medical (NASDAQ:ICUI) brought in sales totaling $543.12 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 291.06%, resulting in a loss of $38.07 million. 
Via Benzinga
Morgan Stanley And 2 Other Stocks Insiders Are Buying
Although US stocks closed sharply higher on Friday, there were a few notable insider trades. 
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc cut PubMatic, Inc. (NASDAQ: PUBM) price target from $48 to $27. PubMatic shares fell 1.5% to $18.71 in pre-market trading. 
Via Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
Via Benzinga
UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market
Health care stocks have some advantages in the current market environment. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback